Pharmaceutical company, Royalty Pharma, to Deliver Presentation at Bernstein's Second Healthcare Conference
Royalty Pharma to Participate in Bernstein's 2 Annual Healthcare Forum
Royalty Pharma, a leading player in healthcare funding, has announced its participation in Bernstein's 2 Annual Healthcare Forum, scheduled for September 23, 2025. The event, held online, will provide a platform for industry leaders to discuss the latest trends and developments in healthcare.
Founded in 1996, Royalty Pharma has been a significant player in the biopharmaceutical industry for over two decades. The company funds innovation both directly and indirectly. Direct funding involves partnering with companies for late-stage trials and new product launches. Indirect funding, on the other hand, comes from acquiring existing royalties from original innovators.
Royalty Pharma's portfolio includes payments based on the top-line sales of many industry-leading therapies. As of 2025, the company's current portfolio includes royalties on over 35 commercial products and 17 development-stage product candidates.
The fireside chat with Royalty Pharma is scheduled for 2:50 p.m. ET on September 23, 2025. The webcast of the event will be accessible from Royalty Pharma's "Events" page at https://www.royaltypharma.com/investors/events/. The webcast will be archived for a minimum of thirty days for those who are unable to attend live.
For more information about Royalty Pharma, its participation in the event, or for investor relations and communications, please contact 1 (212) 883-6637 or [email protected]. You can also visit www.royaltypharma.com for more details. The stock ticker symbol for Royalty Pharma plc is RPRX.
The event is part of Bernstein's ongoing efforts to bring together industry leaders and investors to discuss the future of healthcare. With Royalty Pharma's participation, attendees can expect insightful discussions about the company's role in funding innovation across the biopharmaceutical industry.
Read also:
- Overweight women undergoing IVF have a 47% higher chance of conceiving naturally post-weight loss
- Bonsai Trees from Evergreen Species: Exploring Growth Characteristics & Distinct Qualities
- What temperatures may make walking your canine companion uncomfortable?
- Title: Information About Beovu: Potency, Form, Usage, and Additional Details
